Marc Andreessen, co-founder of Andreessen Horowitz (a16z), joined the U.S. Defense Policy Board on June 29, placing one of Silicon Valley’s most influential venture capitalists at the center of U.S. national security strategy.

Secretary of War Pete Hegseth announced the board, naming former U.S. Trade Representative Robert Lighthizer as chair. Andreessen is one of 13 additional members appointed alongside former Senator Norm Coleman as vice chair.

Andreessen Enters the Pentagon’s Inner Circle

The Defense Policy Board, established in 1985, advises Pentagon leadership on strategic planning, force structure, and national security. Andreessen’s appointment coincides with a16z closing its fifth crypto fund at $2.2 billion. The firm has separately argued that the stablecoin label is outdated, pointing to the technology’s expanding role in global payments.

Furthermore, a16z holds positions in defense-adjacent companies, including Anduril, Shield AI, and Applied Intuition. All three sell into federal defense markets. The board’s advisory scope covers the same procurement priorities that could benefit these holdings.

Still, the Pentagon has not published financial disclosure requirements for the new board. The firm has also closed its London office to concentrate resources in the U.S. market under the current administration.

Andreessen vs. the AI Pessimist Narrative

Andreessen’s response targets crash narratives advanced by historians and macro investors. Alasdair Nairn’s “The Everything Bubble” argued that speculative excess drove tech and AI valuations to fundamentally unsound levels. His thesis holds that they mirror the dynamics that preceded past market collapses.

Andreessen, however, turns the argument around. For the tech billionaire, sustained pessimism is itself a profitable business model. Bear-case forecasters, he argues, deliberately manufacture panic to unsettle investors and exploit the resulting fear financially.

His firm backs that stance with research. a16z published analysis calling the AI job apocalypse a myth. A Barclays AI investor survey flagged Andreessen’s position as a key counterpoint to cautious institutional consensus.

A Financial Interest in the Outcome

Meanwhile, Andreessen Horowitz holds stakes in AI healthcare startups Hippocratic AI and Ambience Healthcare. The firm also manages a $500 million biotech venture fund backed by Eli Lilly. Its bets span a broad swath of the Pentagon’s modernization agenda.

The Defense Policy Board carries no formal procurement authority, but its recommendations reach the Under Secretary for Policy. Andreessen’s Pentagon seat gives a16z unusual policy proximity to decisions that could define the next decade of defense technology. That reach extends well beyond financial exposure into the choices that shape where billions in defense spending flow.

Source: BeInCrypto